180 related articles for article (PubMed ID: 24986112)
1. Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.
Wong AC; Stock S; Schrag D; Kahn KL; Salz T; Charlton ME; Rogers SO; Goodman KA; Keating NL
J Oncol Pract; 2014 Sep; 10(5):e360-7. PubMed ID: 24986112
[TBL] [Abstract][Full Text] [Related]
2. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
3. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
[No Abstract] [Full Text] [Related]
4. Surgeons' volume of colorectal cancer procedures and collaborative decision-making about adjuvant therapies.
Rogers SO; Ayanian JZ; Ko CY; Kahn KL; Zaslavsky AM; Sandler RS; Keating NL
Ann Surg; 2009 Dec; 250(6):895-900. PubMed ID: 19855265
[TBL] [Abstract][Full Text] [Related]
5. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.
Yang L; Ma Q; Yu YY; Wang C; Meng WJ; Adell G; Albertsson M; Arbman G; Jarlsfelt I; Peng ZH; Li Y; Zhou ZG; Sun XF
Medicine (Baltimore); 2014 Dec; 93(28):e266. PubMed ID: 25526455
[TBL] [Abstract][Full Text] [Related]
7. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant systemic therapies in patients with colorectal cancer: an audit on clinical practice in Italy.
Drug Utilization Review Team in Oncology
Tumori; 2005; 91(6):472-6. PubMed ID: 16457144
[TBL] [Abstract][Full Text] [Related]
10. Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists.
Toh JWT; Mahajan H; Chapuis P; Spring K
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1297. PubMed ID: 33030308
[TBL] [Abstract][Full Text] [Related]
11. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.
Dobie SA; Warren JL; Matthews B; Schwartz D; Baldwin LM; Billingsley K
Cancer; 2008 Feb; 112(4):789-99. PubMed ID: 18189291
[TBL] [Abstract][Full Text] [Related]
12. Receipt of recommended therapy by patients with advanced colorectal cancer.
Abraham NS; Gossey JT; Davila JA; Al-Oudat S; Kramer JK
Am J Gastroenterol; 2006 Jun; 101(6):1320-8. PubMed ID: 16771956
[TBL] [Abstract][Full Text] [Related]
13. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
14. Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists.
van Erning FN; Janssen-Heijnen ML; Creemers GJ; Pruijt HF; Maas HA; Lemmens VE
J Geriatr Oncol; 2015 May; 6(3):219-24. PubMed ID: 25703856
[TBL] [Abstract][Full Text] [Related]
15. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
[TBL] [Abstract][Full Text] [Related]
16. Quality of cancer care among foreign-born and US-born patients with lung or colorectal cancer.
Nielsen SS; He Y; Ayanian JZ; Gomez SL; Kahn KL; West DW; Keating NL
Cancer; 2010 Dec; 116(23):5497-506. PubMed ID: 20672356
[TBL] [Abstract][Full Text] [Related]
17. Treatment and referral patterns for colorectal cancer.
Oliveria SA; Yood MU; Campbell UB; Yood SM; Stang P
Med Care; 2004 Sep; 42(9):901-6. PubMed ID: 15319616
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of cancers of the colon and rectum.
Saltz LB; Minsky B
Surg Clin North Am; 2002 Oct; 82(5):1035-58. PubMed ID: 12507208
[TBL] [Abstract][Full Text] [Related]
19. A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.
Lindskog EB; Gunnarsdóttir KÁ; Derwinger K; Wettergren Y; Glimelius B; Kodeda K
BMC Cancer; 2014 Dec; 14():948. PubMed ID: 25495897
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment of colorectal cancer.
Saltz LB; Kelsen DP
Annu Rev Med; 1997; 48():191-202. PubMed ID: 9046955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
